{
    "ticker": "CUBWW",
    "name": "Cubist Pharmaceuticals, Inc.",
    "description": "Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development, and commercialization of innovative medicines to treat serious infections. Founded in 1992, Cubist has established itself as a leader in the fight against antibiotic-resistant bacteria, providing healthcare professionals with effective solutions for challenging infections. The company's flagship product, Cubicin (daptomycin), is used to treat complicated skin and skin structure infections as well as bacteremia and endocarditis caused by Staphylococcus aureus. Cubist is committed to addressing the global public health threat posed by antibiotic resistance through its robust pipeline of novel antibiotics and therapies. The company collaborates with healthcare providers, researchers, and regulatory agencies to advance scientific understanding and improve patient outcomes. With a strong focus on innovation, Cubist is dedicated to delivering high-quality products that make a meaningful difference in the lives of patients and healthcare professionals alike.",
    "industry": [
        "Biopharmaceuticals",
        "Healthcare"
    ],
    "headquarters": "Lexington, Massachusetts, USA",
    "founded": "1992",
    "website": "https://www.cubist.com",
    "ceo": "Robert J. Perez",
    "social_media": {
        "twitter": "https://twitter.com/CubistPharma",
        "linkedin": "https://www.linkedin.com/company/cubist-pharmaceuticals"
    },
    "investor_relations": "https://ir.cubist.com",
    "key_executives": [
        {
            "name": "Robert J. Perez",
            "position": "CEO"
        },
        {
            "name": "Diane C. C. C. Johnson",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Antibiotics",
            "products": [
                "Cubicin"
            ]
        }
    ],
    "seo": {
        "meta_title": "Cubist Pharmaceuticals, Inc. | Innovative Antibiotic Solutions",
        "meta_description": "Learn about Cubist Pharmaceuticals, Inc., a leader in biopharmaceuticals focused on combating antibiotic-resistant infections with innovative solutions.",
        "keywords": [
            "Cubist Pharmaceuticals",
            "Antibiotics",
            "Biopharmaceuticals",
            "Infection Treatment",
            "Cubicin"
        ]
    },
    "faq": [
        {
            "question": "What is Cubist Pharmaceuticals known for?",
            "answer": "Cubist Pharmaceuticals is known for its innovative antibiotics, particularly Cubicin, used to treat serious infections."
        },
        {
            "question": "Who is the CEO of Cubist Pharmaceuticals?",
            "answer": "Robert J. Perez is the CEO of Cubist Pharmaceuticals, Inc."
        },
        {
            "question": "Where is Cubist Pharmaceuticals headquartered?",
            "answer": "Cubist Pharmaceuticals is headquartered in Lexington, Massachusetts, USA."
        },
        {
            "question": "What is Cubicin?",
            "answer": "Cubicin is an antibiotic developed by Cubist Pharmaceuticals for treating complicated skin infections and bacteremia."
        },
        {
            "question": "When was Cubist Pharmaceuticals founded?",
            "answer": "Cubist Pharmaceuticals was founded in 1992."
        }
    ],
    "competitors": [
        "MRK",
        "PFE",
        "AMGN",
        "BMY"
    ],
    "related_stocks": [
        "JNJ",
        "ABBV",
        "GILD",
        "VRTX"
    ]
}